Immunosenescence and Human NK Cells
Is it possible to demonstrate experimentally, an age-associated, but not necessarily an age-dependent change (see Chapter 11 this volume), in human peripheral blood NK activity by a multitechnique approach? The resulting pattern of NK cell dynamics should be qualitatively consistent with different traditional as well as unconventional techniques and experimental conditions used to quantitate the NK activity.
Would such a functional change in NK activity—whether positive or negative— have a cellular basis? If so, would those phenotypic alterations be unique to the aging process?
Are there parallel immunosenescent changes in the non-null cel (T and B) systems? Do the NK cells have an immunoregulatory influence on the non-NK cell immune systems of an aging individual?
KeywordsChromium Covariance Agarose Titration Immobilization
Unable to display preview. Download preview PDF.
- Krishnaraj, R., and Blandford, G., 1985, Natural killer cell activity in human aging: A phenotypic, kinetic and functional assessment, Fed Proc. 43: 593.Google Scholar
- Krishnaraj, R., and Blandford, G., 1986, An Analysis of Human NK cell features that change with age, in: Immunoregulation in Aging ( A. Facchini, J. J. Haaijman, G. Labo, eds.), EURAGE, The Netherlands, pp. 239–245.Google Scholar
- Lanza, E., and Djeu, J. T., 1982, Age-independent natural killer cells activity in murine peripheral blood, NK cells and other natural effector cells, in: NK Cells and Other Natural Effector Cells ( R. B. Herberman, ed.), Academic, Orlando, Florida, pp. 335–340.Google Scholar
- Onsurd, M., 1981, Age dependent changes in some human lymphocyte sub-populations, Acta Pathol. Microbiol. Immunol. Scand. [C] 89: 55–62.Google Scholar
- Roder, J. C., and Kiessling, R., 1978, Target-effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse, Scand. J. Immunol. 8: 135–144.Google Scholar
- Trinchieri, G., and Perussia, B., Human natural killer cells: Biologic and pathologic aspects, Lab. Invest. 50: 489–513.Google Scholar